[EN] SUBSTITUTED INDAZOLE OR INDOLE DERIVATIVES AS IN VITRO MAO-B INHIBITORS<br/>[FR] DÉRIVÉS D'INDAZOLE OU D'INDOLE SUBSTITUÉS EN TANT QU'INHIBITEURS DE MAO-B IN VITRO
申请人:NTZ LAB LTD
公开号:WO2014107771A1
公开(公告)日:2014-07-17
Substituted indazole or imidazole derivatives of formula I as in vitro selective and reversible MAO-B inhibitors and for use in the prevention and treatment of meurodegenerative disorders such as Parkinson's disease, Alzheimer's disase and dementia
I式中取代的吲唑或咪唑衍生物可作为体外选择性和可逆的MAO-B抑制剂,并用于预防和治疗神经退行性疾病,如帕金森病、阿尔茨海默病和痴呆症。